Page last updated: 2024-10-23

azathioprine and Leukemia P388

azathioprine has been researched along with Leukemia P388 in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research Excerpts

ExcerptRelevanceReference
" In 5 transplantable murine tumor models, including sc Sa180, sc Ca755, ip LL and ip leukemias; L1210 and P388 both drugs were found to be antitumor active in all the experiments carried out regardless of dosing regimen or the route of administration."1.28Experimental antitumor activity of new azathioprine analogues. ( Bałoniak, S; Gutsche, W; Hładoń, B; Sikorska, H, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hładoń, B1
Gutsche, W1
Bałoniak, S1
Sikorska, H1

Other Studies

1 other study available for azathioprine and Leukemia P388

ArticleYear
Experimental antitumor activity of new azathioprine analogues.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:1

    Topics: Animals; Antineoplastic Agents; Azathioprine; Cell Survival; Culture Techniques; Humans; KB Cells; L

1989